Publication | Open Access
<scp>COVID</scp> ‐19 Vaccine Response in People with Multiple Sclerosis
150
Citations
33
References
2021
Year
Some disease modifying therapies convey risk of attenuated serological response to SARS-CoV-2 vaccination in people with MS. We provide recommendations for the practical management of this patient group. ANN NEUROL 20219999:n/a-n/a.
| Year | Citations | |
|---|---|---|
Page 1
Page 1